OVID
Price:
$2.3
Market Cap:
$303.33M
Ovid Therapeutics Inc. is a biopharmaceutical firm dedicated to creating significant treatments for individuals and families impacted by neurological disorders across the United States. The company's robust pipeline features several key therapeutic candidates: OV101, a drug candidate currently undergoing Phase 2A clinical trials for Fragile X syndrome; OV329, an inhibitor targeting GABA aminotransferase, aimed at managing seizures linked to tuberous sclerosis complex and infantile spasms; and OV350, a small molecule developed to address various forms of epilepsy. Beyond these, Ovid is also advancing OV882, a short hairpin RNA (shRNA) gene therapy designed to treat Angelman syndrome, and OV81...[Read more]
Industry
Biotechnology
IPO Date
2017-05-05
Stock Exchange
NASDAQ
Ticker
OVID
According to Ovid Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 210.73M. This represents a change of 181.71% compared to the average of 74.80M of the last 4 quarters.
The mean historical Enterprise Value of Ovid Therapeutics Inc. over the last ten years is 102.18M. The current 210.73M Enterprise Value has changed 20.52% with respect to the historical average. Over the past ten years (40 quarters), OVID's Enterprise Value was at its highest in in the June 2020 quarter at 364.12M. The Enterprise Value was at its lowest in in the March 2019 quarter at -1219281.00.
Average
102.18M
Median
103.23M
Minimum
23.12M
Maximum
216.23M
Discovering the peaks and valleys of Ovid Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 422.78%
Maximum Annual Enterprise Value = 216.23M
Minimum Annual Increase = -77.73%
Minimum Annual Enterprise Value = 23.12M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 120.46M | 120.38% |
| 2024 | 54.66M | -74.72% |
| 2023 | 216.23M | 110.63% |
| 2022 | 102.66M | 256.33% |
| 2021 | 28.81M | -54.26% |
| 2020 | 62.99M | -47.88% |
| 2019 | 120.85M | 422.78% |
| 2018 | 23.12M | -77.73% |
| 2017 | 103.80M | -44.84% |
| 2016 | 188.18M | 10.58% |
The current Enterprise Value of Ovid Therapeutics Inc. (OVID) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
130.45M
5-year avg
104.56M
10-year avg
102.18M
Ovid Therapeutics Inc.’s Enterprise Value is greater than Context Therapeutics Inc. (73.47M), less than MacroGenics, Inc. (221.70M), greater than Clene Inc. (76.31M), greater than Oramed Pharmaceuticals Inc. (145.94M), greater than Shattuck Labs, Inc. (148.26M), greater than ImageneBio Inc (-4513289.00), greater than Connect Biopharma Holdings Limited (95.83M), greater than InflaRx N.V. (85.69M), greater than Whitehawk Therapeutics Inc (170.93M), greater than Kalaris Therapeutics Inc (47.97M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 73.47M | $127.71M | |
| 221.70M | $251.71M | |
| 76.31M | $60.20M | |
| 145.94M | $158.38M | |
| 148.26M | $236.64M | |
| -4513289.00 | $63.39M | |
| 95.83M | $133.48M | |
| 85.69M | $115.57M | |
| 170.93M | $205.72M | |
| 47.97M | $80.98M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ovid Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ovid Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Ovid Therapeutics Inc.'s Enterprise Value?
What is the highest Enterprise Value for Ovid Therapeutics Inc. (OVID)?
What is the 3-year average Enterprise Value for Ovid Therapeutics Inc. (OVID)?
What is the 5-year average Enterprise Value for Ovid Therapeutics Inc. (OVID)?
How does the current Enterprise Value for Ovid Therapeutics Inc. (OVID) compare to its historical average?